SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2003
ATRIX LABORATORIES, INC.
--------------------------------------------------
(Exact name of Registrant as Specified in Charter)
Delaware 0-18231 84-1043826
------------------------------ --------------------- -------------------
(State or Other (Commission File No.) (IRS Employer
Jurisdiction of Incorporation) Identification No.)
2579 Midpoint Drive, Fort Collins, Colorado 80525
---------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(970) 482-5868
----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
Item 12. Results of Operations and Financial Condition.
On July 30, 2003, Atrix Laboratories, Inc. issued a press release
announcing its financial results for the quarter ended June 30, 2003. A copy of
the press release is furnished as Exhibit 99.1 to this report. This Form 8-K and
the attached exhibit are furnished to, but not filed with, the Securities and
Exchange Commission.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ATRIX LABORATORIES, INC.
By: /s/Brian G. Richmond
-----------------------------------
Brian G. Richmond
Chief Financial Officer, Secretary
and Treasurer
Date: July 30, 2003
3
EXHIBIT INDEX
EXHIBIT DESCRIPTION
------- ---------------------------------
99.1 Press Release dated July 30, 2003